Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Liver Progenitor Cell Line HepaRG Differentiated in a Bioartificial Liver Effectively Supplies Liver Support to Rats with Acute Liver Failure
by
van der Hoeven, Tessa V.
, Oude Elferink, Ronald P. J.
, Hoekstra, Ruurdtje
, Lamers, Wouter H.
, Maas, Martinus A. W.
, Nibourg, Geert A. A.
, Ruiter, An F. C.
, Chamuleau, Robert A. F. M.
, van Gulik, Thomas M.
in
Ammonia
/ Animals
/ Apolipoprotein A
/ Apolipoproteins
/ Artificial organs
/ Bile ducts
/ Biology
/ Cell cycle
/ Cell death
/ Cell Differentiation
/ Cytochrome
/ Cytochrome P450
/ Dimethyl sulfoxide
/ Drug metabolism
/ Encephalopathy
/ Epidermal growth factor
/ Failure
/ Gene expression
/ Genomes
/ Health care facilities
/ Hepatic encephalopathy
/ Hepatocytes
/ Inflammation
/ Laboratories
/ Lactic acid
/ Liver
/ Liver - pathology
/ Liver diseases
/ Liver failure
/ Liver Failure, Acute - pathology
/ Liver Failure, Acute - therapy
/ Liver transplants
/ Liver, Artificial
/ Medical schools
/ Medicine
/ Metabolism
/ Monomolecular films
/ Progenitor cells
/ Rats
/ Renal failure
/ Reverse Transcriptase Polymerase Chain Reaction
/ Rodents
/ Stem Cells - pathology
/ Surgery
/ Transcription
2012
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Liver Progenitor Cell Line HepaRG Differentiated in a Bioartificial Liver Effectively Supplies Liver Support to Rats with Acute Liver Failure
by
van der Hoeven, Tessa V.
, Oude Elferink, Ronald P. J.
, Hoekstra, Ruurdtje
, Lamers, Wouter H.
, Maas, Martinus A. W.
, Nibourg, Geert A. A.
, Ruiter, An F. C.
, Chamuleau, Robert A. F. M.
, van Gulik, Thomas M.
in
Ammonia
/ Animals
/ Apolipoprotein A
/ Apolipoproteins
/ Artificial organs
/ Bile ducts
/ Biology
/ Cell cycle
/ Cell death
/ Cell Differentiation
/ Cytochrome
/ Cytochrome P450
/ Dimethyl sulfoxide
/ Drug metabolism
/ Encephalopathy
/ Epidermal growth factor
/ Failure
/ Gene expression
/ Genomes
/ Health care facilities
/ Hepatic encephalopathy
/ Hepatocytes
/ Inflammation
/ Laboratories
/ Lactic acid
/ Liver
/ Liver - pathology
/ Liver diseases
/ Liver failure
/ Liver Failure, Acute - pathology
/ Liver Failure, Acute - therapy
/ Liver transplants
/ Liver, Artificial
/ Medical schools
/ Medicine
/ Metabolism
/ Monomolecular films
/ Progenitor cells
/ Rats
/ Renal failure
/ Reverse Transcriptase Polymerase Chain Reaction
/ Rodents
/ Stem Cells - pathology
/ Surgery
/ Transcription
2012
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Liver Progenitor Cell Line HepaRG Differentiated in a Bioartificial Liver Effectively Supplies Liver Support to Rats with Acute Liver Failure
by
van der Hoeven, Tessa V.
, Oude Elferink, Ronald P. J.
, Hoekstra, Ruurdtje
, Lamers, Wouter H.
, Maas, Martinus A. W.
, Nibourg, Geert A. A.
, Ruiter, An F. C.
, Chamuleau, Robert A. F. M.
, van Gulik, Thomas M.
in
Ammonia
/ Animals
/ Apolipoprotein A
/ Apolipoproteins
/ Artificial organs
/ Bile ducts
/ Biology
/ Cell cycle
/ Cell death
/ Cell Differentiation
/ Cytochrome
/ Cytochrome P450
/ Dimethyl sulfoxide
/ Drug metabolism
/ Encephalopathy
/ Epidermal growth factor
/ Failure
/ Gene expression
/ Genomes
/ Health care facilities
/ Hepatic encephalopathy
/ Hepatocytes
/ Inflammation
/ Laboratories
/ Lactic acid
/ Liver
/ Liver - pathology
/ Liver diseases
/ Liver failure
/ Liver Failure, Acute - pathology
/ Liver Failure, Acute - therapy
/ Liver transplants
/ Liver, Artificial
/ Medical schools
/ Medicine
/ Metabolism
/ Monomolecular films
/ Progenitor cells
/ Rats
/ Renal failure
/ Reverse Transcriptase Polymerase Chain Reaction
/ Rodents
/ Stem Cells - pathology
/ Surgery
/ Transcription
2012
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Liver Progenitor Cell Line HepaRG Differentiated in a Bioartificial Liver Effectively Supplies Liver Support to Rats with Acute Liver Failure
Journal Article
Liver Progenitor Cell Line HepaRG Differentiated in a Bioartificial Liver Effectively Supplies Liver Support to Rats with Acute Liver Failure
2012
Request Book From Autostore
and Choose the Collection Method
Overview
A major roadblock to the application of bioartificial livers is the need for a human liver cell line that displays a high and broad level of hepatic functionality. The human bipotent liver progenitor cell line HepaRG is a promising candidate in this respect, for its potential to differentiate into hepatocytes and bile duct cells. Metabolism and synthesis of HepaRG monolayer cultures is relatively high and their drug metabolism can be enhanced upon treatment with 2% dimethyl sulfoxide (DMSO). However, their potential for bioartificial liver application has not been assessed so far. Therefore, HepaRG cells were cultured in the Academic Medical Center bioartificial liver (AMC-BAL) with and without DMSO and assessed for their hepatic functionality in vitro and in a rat model of acute liver failure. HepaRG-AMC-BALs cultured without DMSO eliminated ammonia and lactate, and produced apolipoprotein A-1 at rates comparable to freshly isolated hepatocytes. Cytochrome P450 3A4 transcript levels and activity were high with 88% and 37%, respectively, of the level of hepatocytes. DMSO treatment of HepaRG-AMC-BALs reduced the cell population and the abovementioned functions drastically. Therefore, solely HepaRG-AMC-BALs cultured without DMSO were tested for efficacy in rats with acute liver failure (n = 6). HepaRG-AMC-BAL treatment increased survival time of acute liver failure rats ∼50% compared to acellular-BAL treatment. Moreover, HepaRG-AMC-BAL treatment decreased the progression of hepatic encephalopathy, kidney failure, and ammonia accumulation. These results demonstrate that the HepaRG-AMC-BAL is a promising bioartificial liver for clinical application.
Publisher
Public Library of Science,Public Library of Science (PLoS)
Subject
MBRLCatalogueRelatedBooks
Related Items
Related Items
We currently cannot retrieve any items related to this title. Kindly check back at a later time.
This website uses cookies to ensure you get the best experience on our website.